Consulting firms are encroaching on the advertising business. Here's why Burger King's top marketing exec doesn't buy into the consulting firm hype.

Tanya Dua | Burger King's global chief marketing officer Fernando Machado said that he prefers working with ad agencies over consulting firms.

Read More »

Marketing cloud startup Zeta Global is acquiring the assets of bankrupt ad-tech firm Sizmek to help marketers run campaigns with first-party data

Lauren Johnson | Zeta Global is acquiring Sizmek for a reported $40 million.

Read More »

Video-conferencing company Zoom soared 81% in its first day of public trading — now its CEO and CFO are focusing on these 3 goals

Rosalie Chan | Zoom went public on Thursday, and shares soared 81%. CEO Eric Yuan and CFO Kelly Steckelberg talked about Zoom's next goals and the secret to profitability.

Read More »

A healthcare VC who helps oversee $1.1 billion reveals the biggest mistake she made and how it shapes her investments today

Lydia Ramsey | Annie Lamont's backed some of the biggest names in health tech. In an interview, she told us the biggest mistakes she made and what she learned.

Read More »

The ultimate guide to nailing your job interview

Shana Lebowitz | This comprehensive list of interview tips — from what to wear to how to shake hands — will get you one step closer to your dream job.

Read More »

Blend, a startup that's building a 'one tap' mortgage-application tool, is now jumping into the auto-loan market

Alex Morrell | Blend has been working toward an ambitious goal of reducing the mortgage-application process to a single tap — and autos loans are next.

Read More »

The stars are aligning for more explosive stock gains — and one expert has identified the perfect trade to take advantage

Marley Jay | Julian Emanuel of BTIG says stocks can build on their huge gains since Christmas Eve, at least if historical precedent is to be believed.

Read More »

'Vulnerable to catastrophe': One market bear explains why stocks will crash 30% by the end of 2019 — and then flatline for the next 12 years

Joe Ciolli | The renowned market bear John Hussman lays out why he thinks the S&P 500 is in for a tough, money-losing road ahead.

Read More »

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease

Erin Brodwin | Insitro and Gilead are teaming up to create drugs for a liver disease affecting millions. The startup is backed by Jeff Bezos and Andreessen Horowitz.

Read More »